Skip to Content

Dapsone topical Pregnancy and Breastfeeding Warnings

Dapsone topical is also known as: Aczone

Medically reviewed on May 14, 2018

Dapsone topical Pregnancy Warnings

Animal studies have shown embryocidal effects. There are no adequate and well controlled studies in pregnant women.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.

US FDA pregnancy category: C

See references

Dapsone topical Breastfeeding Warnings

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother.

Excreted into human milk: Yes

Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Aczone (dapsone topical)." QLT USA, Inc, Fort Collins, CO.

References for breastfeeding information

  1. "Product Information. Aczone (dapsone topical)." QLT USA, Inc, Fort Collins, CO.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide